+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risk factors for neovascular age-related macular degeneration



Risk factors for neovascular age-related macular degeneration



Archives of Ophthalmology 110(12): 1701-1708



Neovascular age-related macular degeneration (AMD) is one of five retinal disorders studied in the Eye Disease Case-Control Study. Data were obtained from 421 patients with neovascular AMD and 615 controls on a broad array of possible risk factors through interviews, clinical examinations, and laboratory analyses of blood samples. Decreased risk of neovascular AMD was associated with higher levels of carotenoids in the serum samples, higher horizontal cup-to-disc ratios, and use of potmenopausal exogneous estrogens in women. Increased risk of neovascular AMD was associated with cigarette smoking, higher levels of serum cholesterol, and parity greater than zero. No support was found for sunlight exposure, serum zinc levels, or iris color as risk factors for this disease. Although no association was found with a history of cardiovascular disease itself, the associations with post-menopausal exogneous estrogen use, cigarette smoking, and serum cholesterol level are consistent with a hypothesis linking risk factors for cardiovascular disease with neovascular AMD. The association noted between serum carotenoid levels and neovascular AMD supports the hypothesis that higher levels of micronutrients with antioxidant capabilities may decrease the risk of AMD.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009965627

Download citation: RISBibTeXText

DOI: 10.1001/archopht.1992.01080240041025


Related references

Incidence and risk factors for macular hemorrhage following intravitreal ranibizumab injection for neovascular age-related macular degeneration. Journal of Ocular Pharmacology and Therapeutics 29(6): 556-559, 2013

Nongenetic risk factors for neovascular age-related macular degeneration. Investigative Ophthalmology and Visual Science 55(8): 5228-5232, 2014

Risk Factors for Discontinuation of Treatment for Neovascular Age-Related Macular Degeneration. Ophthalmic Epidemiology 25(2): 176-182, 2018

Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye. Graefe's Archive for Clinical and Experimental Ophthalmology 256(11): 2061-2068, 2018

Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration. Molecular Vision 14: 1487-1495, 2008

Assessment of retinal vessel caliber changes in eyes with non-neovascular age-related macular degeneration after progression to neovascular age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology 254(3): 599-601, 2016

Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Retina 33(4): 841-845, 2013

Risk Factors and Clinical Significance of Prechoroidal Cleft in Neovascular Age-Related Macular Degeneration. Retina 37(11): 2047-2055, 2017

Clinical risk factors for poor anatomic response to ranibizumab in neovascular age-related macular degeneration. Open Ophthalmology Journal 8: 3-6, 2014

Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration. Archives of Ophthalmology 122(4): 575-580, 2004

Development and testing of a patient-derived questionnaire for treatment of neovascular age-related macular degeneration: dimensions of importance in treatment of neovascular age-related macular degeneration. Acta Ophthalmologica 96(8): 804-811, 2018

Risk factors of a reduced response to ranibizumab treatment for neovascular age-related macular degeneration--evaluation in a clinical setting. Bmc Ophthalmology 13: 84, 2013

Risk factors for conversion to neovascular age-related macular degeneration based on longitudinal morphologic and visual acuity data. Ophthalmology 119(7): 1432-1437, 2012

A69S and R38X ARMS2 and Y402H CFH gene polymorphisms as risk factors for neovascular age-related macular degeneration in Poland - a brief report. Medical Science Monitor 18(2): Pr1, 2012

Retinal pigment epithelium rips after ranibizumab in neovascular age-related macular degeneration: incidence, risk factors and long-term outcome. Klinische Monatsblatter für Augenheilkunde 231(4): 432-435, 2014